Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of Ultrashort-Acting β-Blockers on Mortality in Patients With Sepsis With Persistent Tachycardia Despite Initial Resuscitation

Published:2021-06 Issue:6 Volume:159 Page:2289-2300
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Hasegawa Daisuke,Sato Ryota,Prasitlumkum Narut,Nishida Kazuki,Takahashi Kunihiko,Yatabe Tomoaki,Nishida Osamu

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference34 articles.

1. Severe sepsis and septic shock;Angus;N Engl J Med,2013

2. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis;Parker;Crit Care Med,1987

3. Long-term outcomes following development of new-onset atrial fibrillation during sepsis;Walkey;Chest,2014

4. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: a multicentre evaluation;Domizi;J Crit Care,2020

5. The treatment of endotoxin shock by beta adrenergic blockade;Berk;Ann Surg,1969

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of esmolol in sepsis: a meta-analysis based on randomized controlled trials;BMC Anesthesiology;2024-09-12

2. Impact of β-blockers on in-hospital mortality in patients with heart failure: a retrospective propensity-score matched analysis based on MIMIC-IV database;Frontiers in Pharmacology;2024-08-13

3. The pros and cons of beta-blockers in sepsis: Where do we stand in 2024?;Journal of Intensive Medicine;2024-08

4. Mortality in Patients With Sepsis Treated With Esmolol or Landiolol;CHEST;2024-08

5. Effect of ultrashort-acting β-blockers on 28-day mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a meta-analysis of randomized controlled trials and trial sequential analysis;Frontiers in Pharmacology;2024-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3